MolNFT v2 · #115087 · protein
Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disease
MolNFT v2 record #115087 on GenesisL1: PDB 5C0N, “Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disease”. Protein, 222 residues. 3D structure, sequence proof, BLAST and structure…
- PDB
- 5C0N
- Type
- protein
- Length
- 222 residues
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.